Business
Stem Cell Therapy
Organoid
Stem Cell and CDMO Business
R&D
Core Technology
Kangstem Biotech was founded with the goal of developing stem cell therapies for rare and intractable diseases. Since its establishment in 2010, Kangstem Biotech has been dedicated to developing umbilical cord blood–derived stem cell therapeutics. Building on the R&D capabilities and core technologies we have accumulated over the years, we will advance the development of innovative new drugs, commercialize our therapies, and expand into global markets—growing beyond Korea to become a leading global company in stem cell therapeutics.
'Noble Life & Healthy Ageing'
This is the future Kangstem Biotech envisions for humanity. We will continue to strive to usher in an era of living to 100 with happiness and vitality—and to create a future not simply defined by longevity, but one in which everyone can live a healthy and fulfilling life.
Kangstem Biotech will remain fully committed to developing fundamental, disease-modifying treatments for patients with rare and intractable conditions.
Thank you.
Founder, Kang Kyung-sun
CEO, Na Jong-cheon
All executives and employees of Kangstem Biotech Co., Ltd.